English
  • Abrocitinib

    Abrocitinib

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Abrocitinib Atopic Dermatitis Pfizer Feb.11, 2034
    inquirydetail
  • Agomelatine

    Agomelatine

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Agomelatine Depression In-House √    
    inquirydetail
  • Apixaban

    Apixaban

    API’s Name Indication Specification US DMF EU DMF CEP
    Apixaban VTE In-House
    inquirydetail
  • Atorvastatin Calcium

    Atorvastatin Calcium

    API’s Name Indication Specification US DMF EU DMF CEP
    Atorvastatin Calcium Hypercholesterolemia In-House/CEP 29057 √ CEP 2015-034
    inquirydetail